Loading…
BFRI
Biofrontera Inc.
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP 09077D209
$1.59+6.71%Price as of Aug 29, 18:44 UTC · updated once a day, after the close
Key metrics
- Market cap
- $23.62M
- P/E
- —
- Forward P/E
- 3.7x
- P/B
- 3.8x
- Dividend yield
- —
- Payout
- —
- EPS
- -$0.43
- ROE
- -988.35%
- Profit margin
- -13.79%
- Revenue growth
- +32.90%
- Beta
- 0.80
- 52-week high
- $1.61
- 52-week low
- $0.56
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -98.7% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 5 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Year-end price | $0.57 | $1.09 | $2.77 | $18.34 | $150.40 | |
| P/S | 0.4x | 0.2x | 0.3x | 0.4x | 0.9x | 5.3x |
| P/B | 2.2x | 0.6x | 2.2x | 2.9x | 1.0x | 11.3x |
| EPS | -$1.04 | -$3.22 | -$13.02 | -$0.61 | -$85.60 |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ENLVEnlivex Ltd. | $1.35 | 0.0x | 0.0x | — | 126.17% | $23.61M |
| NXTCNextCure, Inc. | $5.18 | — | 1.7x | — | -204.56% | $23.71M |
| CLRBCellectar Biosciences, Inc. | $2.53 | — | 0.7x | — | -119.57% | $23.91M |
| JSPRJasper Therapeutics, Inc. | $0.70 |
About the company
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
- 84
- Woburn, United States
Company description provided by Yahoo Finance.